Actavis Tells Testosterone MDL Court It’s Reached Potential Global Settlement

Mealey's (July 11, 2018, 10:06 AM EDT) -- CHICAGO — Actavis Inc. and related entities on June 28 told the testosterone replacement therapy multidistrict litigation court that it has entered into a memorandum of understanding with plaintiff attorneys for a potential global settlement, including all filed cases (In Re:  Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.)....

Attached Documents

Related Sections